139 related articles for article (PubMed ID: 8200572)
21. Diagnostic clues for early pancreatic cancer.
Furukawa H
Jpn J Clin Oncol; 2002 Oct; 32(10):391-2. PubMed ID: 12451033
[No Abstract] [Full Text] [Related]
22. Comparison of two newly identified tumor markers (CAR-3 and DU-PAN-2) with CA 19-9 in patients with pancreatic cancer.
Ferrara C; Basso D; Fabris C; Malesci A; Fogar P; Meggiato T; Panozzo MP; Scalon P; Del Favero G; Plebani M
Tumori; 1991 Feb; 77(1):56-60. PubMed ID: 1673269
[TBL] [Abstract][Full Text] [Related]
23. [Increased levels of Ca 19-9, Ca 50 and Ca 125 in patients with benign diseases of the biliary tract and the pancreas].
Piantino P; Fusaro A; Randone A; Cerchier A; Daziano E
J Nucl Med Allied Sci; 1990; 34(4 Suppl):97-102. PubMed ID: 2092159
[TBL] [Abstract][Full Text] [Related]
24. Clinical relevance of tumour markers CA 19-9 and CA-50 in sera from patients with pancreatic duct carcinoma.
Von Rosen A; Linder S; Harmenberg U; Wiechel KL
Surg Oncol; 1992 Apr; 1(2):109-13. PubMed ID: 1341241
[TBL] [Abstract][Full Text] [Related]
25. How does liver dysfunction influence serum CA 19-9 in pancreatic cancer?
Basso D; Fabris C; Del Favero G; Piccoli A; Angonese C; Pasquali C; Castoro C; Plebani M; Leandro G; Burlina A
Ital J Gastroenterol; 1990 Feb; 22(1):1-6. PubMed ID: 2131920
[TBL] [Abstract][Full Text] [Related]
26. NIH state-of-the-science statement on endoscopic retrograde cholangiopancreatography (ERCP) for diagnosis and therapy.
NIH Consens State Sci Statements; 2002 Jan 14-16; 19(1):1-26. PubMed ID: 14768653
[TBL] [Abstract][Full Text] [Related]
27. [Pancreatic cancer or autoimmune pancreatitis: endosonography as a diagnostic reviser].
Szepes Z; Dobra M; Góg C; Zábrák E; Makula É; Tiszlavicz L; Kiss T; Molnár T; Nagy F; Czakó L; Terzin V; Wittmann T
Orv Hetil; 2013 Jan; 154(2):62-8. PubMed ID: 23291204
[TBL] [Abstract][Full Text] [Related]
28. Focal chronic pancreatitis: false-positive fine-needle biopsy.
Vergote G; De Man R; Rutgeerts L
J Belge Radiol; 1994 Oct; 77(5):229. PubMed ID: 7961386
[No Abstract] [Full Text] [Related]
29. Clinical value of serum tumour markers CEA, CA 50 and CA 242 in the distinction between malignant versus benign diseases causing jaundice and cholestasis; results from a prospective study.
Pasanen PA; Eskelinen M; Partanen K; Pikkarainen P; Penttilä I; Alhava E
Anticancer Res; 1992; 12(5):1687-93. PubMed ID: 1332581
[TBL] [Abstract][Full Text] [Related]
30. Is CA242 really a new tumour marker for pancreatic adenocarcinoma?
Plebani M; Basso D; Navaglia F; D'Angeli F; Panozzo MP; Del Giudice G; Battistel M; Meggiato T; Del Favero G
Oncology; 1995; 52(1):19-23. PubMed ID: 7800337
[TBL] [Abstract][Full Text] [Related]
31. [Is jaundice a cause of error in the interpretation of CA 19-9 blood levels?].
Nakad A; Colombel JF; Geubel AP; Cerulus G; Farchakh E; Degrez T; Janssen J; Cortot A; Paris JC; Dive C
Acta Gastroenterol Belg; 1989; 52(1-2):17-22. PubMed ID: 2618531
[TBL] [Abstract][Full Text] [Related]
32. CA 15.3 in nonmalignant liver diseases.
Collazos J; Genollá J; Ruibal A
Int J Biol Markers; 1991; 6(3):188-92. PubMed ID: 1791313
[TBL] [Abstract][Full Text] [Related]
33. Ductectatic mucinous cystadenocarcinoma of the pancreas: a rare variant.
Kakkos SK; Vagenas CA; Spiliotis JD; Thomopoulos C; Androulakis JA
Hepatogastroenterology; 1998; 45(24):2410-2. PubMed ID: 9951933
[TBL] [Abstract][Full Text] [Related]
34. CA 125 serum levels in patients with non-neoplastic liver diseases. A clinical and laboratory study.
Collazos J; Genolla J; Ruibal A
Scand J Clin Lab Invest; 1992 May; 52(3):201-6. PubMed ID: 1411252
[TBL] [Abstract][Full Text] [Related]
35. Clinical utility of the serum CA 19-9 test for diagnosing pancreatic carcinoma in symptomatic patients: a prospective study.
Malesci A; Montorsi M; Mariani A; Santambrogio R; Bonato C; Bissi O; Tacconi M; Wizemann G; Spina G
Pancreas; 1992; 7(4):497-502. PubMed ID: 1641392
[TBL] [Abstract][Full Text] [Related]
36. [Tumour markers of pancreatic cancer (tumour associated antigens)].
Groblewska M; Mroczko B; Szmitkowski M
Pol Arch Med Wewn; 2005 Jun; 113(6):585-93. PubMed ID: 16454450
[No Abstract] [Full Text] [Related]
37. The value of a pancreatogram in chronic pancreatitis diagnosed by endoscopic retrograde cholangiopancreatography.
Hernández Garcés HR; Lazo del Vallin S; Moutary I
JOP; 2004 Jan; 5(1):25-31. PubMed ID: 14730119
[TBL] [Abstract][Full Text] [Related]
38. Autoimmune pancreatitis mimicking cancer of the head of pancreas: report of two cases.
Servais A; Pestieau SR; Detry O; Honoré P; Belaïche J; Boniver J; Jacquet N
Acta Gastroenterol Belg; 2001; 64(2):227-30. PubMed ID: 11475142
[TBL] [Abstract][Full Text] [Related]
39. Double-duct-sign--is it always cancer?
Schlauch D; Kohler B; Riemann JF
Endoscopy; 1993 Sep; 25(7):489-90. PubMed ID: 8261999
[No Abstract] [Full Text] [Related]
40. The value of endoscopic retrograde cholangiopancreatography in patients with suspected carcinoma of the pancreas and indeterminate computed tomographic results.
Frick MP; Feinberg SB; Goodale RL
Surg Gynecol Obstet; 1982 Aug; 155(2):177-82. PubMed ID: 7101106
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
